Chugai Pharmaceutical Co., Ltd. (TYO:4519)
10,455
+160 (1.55%)
At close: Feb 27, 2026
Chugai Pharmaceutical Market Cap
Chugai Pharmaceutical has a market cap or net worth of 17.21 trillion as of February 27, 2026. Its market cap has increased by 55.27% in one year.
Market Cap
17.21T
Enterprise Value
16.23T
Revenue
1.26T
Ranking
n/a
PE Ratio
39.64
Stock Price
10,455.00
Market Cap Chart
Since January 6, 1992, Chugai Pharmaceutical's market cap has increased from 310.35B to 17.21T, an increase of 5,443.96%. That is a compound annual growth rate of 12.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 17.21T | 26.84% |
| Dec 30, 2025 | 13.57T | 17.79% |
| Dec 30, 2024 | 11.52T | 31.04% |
| Dec 29, 2023 | 8.79T | 58.64% |
| Dec 30, 2022 | 5.54T | -9.78% |
| Dec 30, 2021 | 6.14T | -32.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Daiichi Sankyo Company | 5.66T |
| Otsuka Holdings | 5.66T |
| Astellas Pharma | 4.66T |
| Kyowa Kirin | 1.51T |
| Ono Pharmaceutical | 1.26T |
| Santen Pharmaceutical | 562.44B |
| JCR Pharmaceuticals | 84.66B |
| Perseus Proteomics | 3.45B |